PT  - JOURNAL ARTICLE
AU  - Marzoog, Basheer Abdullah
AU  - Gognieva, Daria
AU  - Chomakhidze, Peter
AU  - Kopylov, Philipp
TI  - Cardi-Ankle Vascular Index Optimizes Ischemic Heart disease Diagnosis
AID  - 10.1101/2024.07.03.24309877
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.03.24309877
4099  - http://medrxiv.org/content/early/2024/07/05/2024.07.03.24309877.short
4100  - http://medrxiv.org/content/early/2024/07/05/2024.07.03.24309877.full
AB  - Background Ischemic heart disease (IHD) has the highest mortality rate in the globe in between the other cardiovascular diseases (CVD). This returns to the poor diagnostic and therapeutic strategies including the primary prevention techniques.Aims To assess the changes in the cardio-ankle vascular index (CAVI) in patients with vs without IHD confirmed by stress computed tomography myocardial perfusion (CTP) imaging with vasodilatation stress-test (Adenosine triphosphate).Objectives IHD often has preventable risk factors and causes that lead to the appearance of the disease. However, the lack of appropriate diagnostic and prevention tools remains a global challenge in or era despite current scientific advances.Material and methods A single center observational study included 80 participants from Moscow. The participants aged ≥ 40 years and given a written consent to participate in the study. Both groups, G1=31 with vs. G2 = 49 without post stress induced myocardial perfusion defect, received cardiologist’s consultation, anthropometric measurements, blood pressure and pulse rate, echocardiography, CAVI and performing bicycle ergometry. For statistical analysis, descriptive statistics, t-test independent by groups and dependent by numerical variables for repeated analysis for the same patients, Pearson’s correlation coefficient, multivariate ANOVA test, and for clarification purposes, diagrams and bar figures were used. For performing the statistical analysis, used the Statistica 12 programme (StatSoft, Inc. (2014). STATISTICA (data analysis software system), version 12. www.statsoft.com.) and the IBM SPSS Statistics, version 28.0.1.1 (14).Results The mean age of the participants 56.28, standard deviation (Std.Dev. ± 10.601). Mean CAVI in the IHD group 8.509677 (Std.Dev. ± 0.975057208) vs 7.994898 (Std.Dev. ± 1.48990509) in the non-IHD group. The mean estimated biological age of the arteries according to the results of the CAVI in the first group 61.2258 years vs 53.5102 years in the second group. The Mean brachial-ankle pulse (Tba) in the IHD group 82.0968 vs 89.0102 in the second group. The mean heart-ankle pulse wave velocity (haPWV; m/s) in the IHD group was 0.9533 vs 0.8860 in the second group. Regression analysis demonstrated that the dependent variable, the CAVI parameter, have no significant effect on the development of stress-induced myocardial perfusion defect, regression coefficient 95.316, p>0.05. The CAVI showed 64 % diagnostic accuracy for the IHD.Conclusion The CAVI parameter showed no statistical difference between the participants with IHD vs without. The CAVI parameter can be used as an axillary method for improving the diagnosis of IHD.Other Additional indicators associated with IHD include the Tba and haPWV parameters, higher in patients with IHD.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT06181799Funding StatementThe work of Philipp Kopylov and Daria Gognieva was financed by the government assignment 1023022600020-6 "Application of mass spectrometry and exhaled air emission spectrometry for cardiovascular risk stratification". The work of Basheer Marzoog and Peter Chomakhidze was financed by the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Center "Digital biodesign and personalized healthcare" № 075-15-2022-304.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the study approved by the Sechenov University, Russia, from 'Ethics Committee Requirement № 19-23 from 26.10.2023'.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptCVDcardiovascular diseaseCTPstress computed tomography myocardial perfusion imagingIHDischemic heart disease